Literature DB >> 29507024

Spontaneous splenic rupture due to rivaroxaban.

Vinayak Nagaraja1, Greg Cranney1, Virag Kushwaha1.   

Abstract

In the prevention and treatment of thromboembolic disease, novel oral anticoagulants have emerged as alternatives to warfarin. A major challenge continues to be the reversal of their anticoagulant effect in the case of life-threatening haemorrhagic complications. We report a case of spontaneous splenic rupture treated by splenic artery embolisation in a 77-year-old woman who was anticoagulated with rivaroxaban. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  arrhythmias; drugs and medicines

Mesh：

Substances：

Year:  2018        PMID： 29507024      PMCID： PMC5847924          DOI： 10.1136/bcr-2017-223237

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  21 in total

1.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip
Journal:  Chest       Date:  2010-03-18       Impact factor: 9.410

Review 2.  New Oral Anticoagulants and Their Reversal.

Authors:  Ian Pinto; Anshu Giri; Umbreen Arshad; Ajeet Gajra
Journal:  Curr Drug Saf       Date:  2015

3.  Spontaneus splenic rupture in a patient treated with rivaroxaban.

Authors:  Jonathan Gonzva; Roland Patricelli; David Lignac
Journal:  Am J Emerg Med       Date:  2014-02-04       Impact factor: 2.469

4.  Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation.

Authors:  Charles Haviland Moore; Jonathan Snashall; Keith Boniface; James Scott
Journal:  Am J Emerg Med       Date:  2011-12-23       Impact factor: 2.469

5.  A new scoring system (DAIGA) for predicting bleeding complications in atrial fibrillation patients after drug-eluting stent implantation with triple antithrombotic therapy.

Authors:  Norihiro Kobayashi; Masahiro Yamawaki; Masatsugu Nakano; Keisuke Hirano; Motoharu Araki; Hideyuki Takimura; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Yoshiaki Ito
Journal:  Int J Cardiol       Date:  2016-08-22       Impact factor: 4.164

6.  A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.

Authors:  Genmin Lu; Francis R DeGuzman; Stanley J Hollenbach; Mark J Karbarz; Keith Abe; Gail Lee; Peng Luan; Athiwat Hutchaleelaha; Mayuko Inagaki; Pamela B Conley; David R Phillips; Uma Sinha
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440

7.  Use of PER977 to reverse the anticoagulant effect of edoxaban.

Authors:  Jack E Ansell; Sasha H Bakhru; Bryan E Laulicht; Solomon S Steiner; Michael Grosso; Karen Brown; Victor Dishy; Robert J Noveck; James C Costin
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245

8.  Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.

Authors:  Antonio J Carcas; Alberto M Borobia; Marta Velasco; Francisco Abad-Santos; Manuel Quintana Díaz; Carmen Fernández-Capitán; Nuria Ruiz-Giménez; Olga Madridano; Pilar Llamas Sillero
Journal:  Trials       Date:  2012-12-13       Impact factor: 2.279

9.  Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.

Authors:  Martin H Prins; Anthonie Wa Lensing; Rupert Bauersachs; Bonno van Bellen; Henri Bounameaux; Timothy A Brighton; Alexander T Cohen; Bruce L Davidson; Hervé Decousus; Gary E Raskob; Scott D Berkowitz; Philip S Wells
Journal:  Thromb J       Date:  2013-09-20

10.  Spontaneous splenic rupture associated with apixaban: a case report.

Authors:  Lacy E Lowry; Jonathan A Goldner
Journal:  J Med Case Rep       Date:  2016-08-09
View more
  1 in total

1.  Atraumatic splenic rupture in a patient treated with apixaban: A case report.

Authors:  Ho-Cing Victor Yau; Sharin Pradhan; Lingjun Mou
Journal:  Int J Surg Case Rep       Date:  2020-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.